Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different.

Hiatt, William R; Hess, Connie N; Bonaca, Marc P

Hiatt, William R; Hess, Connie N; Bonaca, Marc P.

Afiliação

Hiatt WR; University of Colorado School of Medicine, Department of Medicine, Division of Cardiology, and CPC Clinical Research, Aurora, Colorado. Electronic address: Will.Hiatt@cpcmed.org.
Hess CN; University of Colorado School of Medicine, Department of Medicine, Division of Cardiology, and CPC Clinical Research, Aurora, Colorado.
Bonaca MP; University of Colorado School of Medicine, Department of Medicine, Division of Cardiology, and CPC Clinical Research, Aurora, Colorado. Electronic address: https://twitter.com/MarcBonaca.

J Am Coll Cardiol ; 73(25): 3292-3294, 2019 07 02.

Article em En | MEDLINE | ID: mdl-31248550

Assuntos

Aspirina; Rivaroxabana; Inibidores do Fator Xa; Inibidores da Agregação Plaquetária

Palavras-chave

clinical trials; drug therapy; peripheral artery disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspirina / Rivaroxabana Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google